Late atrial appendage perforation from a pacemaker lead pacemaker complication

2013 ◽  
Vol 22 (1) ◽  
pp. 83-85 ◽  
Author(s):  
Georgios Souretis ◽  
Christophoros Kotoulas ◽  
Panagiotis Xapladeris ◽  
Dimitrios Flessas ◽  
Nikolaos Laschos ◽  
...  
Keyword(s):  
Atrial Appendage ◽  
Pacemaker Lead ◽  
Pacemaker Complication

scholarly journals Development of Pacemaker Lead Thrombosis in a Patient with Atrial Fibrillation during Apixaban Treatment

2019 ◽  
Author(s):  
Adem Adar ◽  
Orhan Önalan ◽  
Fahri Cakan
Keyword(s):  
Atrial Fibrillation ◽  
Female Patient ◽  
Left Atrial ◽  
Foreign Bodies ◽  
Left Atrial Appendage ◽  
Atrial Appendage ◽  
Clinical Use ◽  
Pacemaker Lead ◽  
Nonvalvular Atrial Fibrillation ◽  
Pacemaker Leads

Apixaban was introduced in clinical use for nonvalvular atrial fibrillation as an alternative to warfarin. There is a dearth of information regarding apixaban use in patients suffering from atrial fibrillation with intracardiac foreign bodies such as pacemaker leads. In this report, we describe a 72-year-old female patient with a complaint of weakness in both legs of a few days’ duration. She was detected to have a thrombus over the pacemaker lead and inside the left atrial appendage during apixaban treatment. After the discontinuation of apixaban and the commencement of warfarin, the thrombus was resolved. Our case is the first report to show that apixaban treatment (5 mg, twice daily) may not prevent the development of pacemaker lead thrombosis in patients with atrial fibrillation.   J Teh Univ Heart Ctr 2019;14(4):183-186   This paper should be cited as: Adem Adar, Orhan Önalan, Fahri Cakan. Development of Pacemaker Lead Thrombosis in a Patient with Atrial Fibrillation during Apixaban Treatment. J Teh Univ Heart Ctr 2019;14(4):183-186

452 Value of new diagnostic criteria in pacemaker lead endocarditis

1999 ◽  
Vol 1 ◽  
pp. S75-S75
Author(s):  
G HABIB ◽  
P BARNAY ◽  
J AVIERINOS ◽  
G DERUMEAUX ◽  
J LEFEVRE ◽  
...  
Keyword(s):  
Diagnostic Criteria ◽  
Pacemaker Lead ◽  
Lead Endocarditis

Rationale and trial design of the Left Atrial Appendage Occlusion Study (LAAOS III)

2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
W. Reents ◽  
A. Diegeler ◽  
J. Babin-Ebell ◽  
A. Böning ◽  
R.P. Whitlock
Keyword(s):  
Left Atrial ◽  
Trial Design ◽  
Left Atrial Appendage ◽  
Atrial Appendage ◽  
Left Atrial Appendage Occlusion

Stroke Prophylaxis by Percutaneous Closure of Patent Foramen Ovale and Left Atrial Appendage

2011 ◽  
Vol 6 (1) ◽  
pp. 67
Author(s):  
Antonio L Bartorelli ◽  
Claudio Tondo ◽  
◽  
Keyword(s):  
Left Atrial ◽  
Patent Foramen Ovale ◽  
Stroke Risk ◽  
Left Atrial Appendage ◽  
Cryptogenic Stroke ◽  
Atrial Appendage ◽  
Foramen Ovale ◽  
Percutaneous Procedures ◽  
Cerebrovascular Events

Innovative percutaneous procedures for stroke prevention have emerged in the last two decades. Transcatheter closure of the patent foramen ovale (PFO) is performed in patients who suffered a cryptogenic stroke or a transient ischaemic attach (TIA) in order to prevent recurrence of thromboembolic events. Percutaneous occlusion of the left atrial appendage (LAA) has been introduced to reduce stroke risk in patients with atrial fibrillation (AF). The role of PFO and LAA in the occurrence of cerebrovascular events and the interventional device-based therapies to occlude the PFO and LAA are discussed.

Sign in / Sign up

Export Citation Format

Share Document